Showing 11 - 20 of 91 results
Policy Snapshot
May 31, 2024
A new Morbidity and Mortality Weekly Report (MMWR) highlights safety findings for two respiratory syncytial virus (RSV) vaccines licensed by the Food and Drug Administration (FDA) in May 2023 for adults 60 years of age and older.
PALTmed In The News
August 23, 2024
Two new COVID vaccines were approved for use late last week, and experts continue to encourage seniors to get the booster, but payment issues for nursing homes and long-term care pharmacies complicate access for residents.
JAMDA
July 20, 2021
Vaccines are critical to protect both nursing home residents and staff from COVID-19, but some staff have expressed reservations about being vaccinated. In this brief report, we describe interventions that Genesis HealthCare—one of the largest US long-term care providers—implemented after recognizing midwa...
JAMDA
February 15, 2019
Influenza is a leading cause of admissions for nursing home (NH) residents. We previously evaluated the effectiveness of a high-dose trivalent influenza vaccine (HD) compared to a standard-dose influenza vaccine (SD) through a cluster-randomized trial of NH residents. Fewer residents from facilities rando...
JAMDA
March 20, 2021
The vaccination of skilled nursing facility (SNF) staff is a critical component in the battle against COVID-19. Together, residents and staff constitute the single most vulnerable population in the pandemic. The health of these workers is completely entangled with the health of those they care for. Vaccina...
JAMDA
June 7, 2023
To investigate the association of using informal sources and reliance on multiple sources of information with actual COVID-19 vaccine uptake, the number of doses of vaccine received, COVID-19 testing, essential preventive measures, and perceived severity of COVID-19.
JAMDA
January 6, 2023
To assess the federal COVID-19 vaccine mandate's effects on nursing homes' nurse aide and licensed nurse staffing levels in states both with and without state-level vaccine mandates.
JAMDA
February 23, 2022
To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19.
JAMDA
August 25, 2021
In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program to facilitate COVID-19 vaccination of residents and staff in long-term care facilities (LTCFs), including assisted living (AL) and other residential care (RC) communities. We aimed to assess vaccine uptake in these communiti...
Podcast
September 4, 2024
In Episode 2 of our two-part series, host Elizabeth Sobczyk, MSW, MPH, and special guest Leslie Eber, MD, CMD, share practical strategies for clinicians to enhance conversations about the COVID-19 vaccine and highlight leadership actions that have successfully increased vaccination rates in PALTC. We also ...